M&A dominated today's headlines, with Weir Group expanding its South American footprint, Chesnara receiving UK regulatory approval for its HSBC Life acquisition, and SolGold signaling potential board recommendation for a revised takeover offer from Jiangxi Copper. Alongside Neo Energy Metals' progress on its Beisa mine acquisition, companies focused on financial strength and shareholder value; Taylor Maritime announced a significant capital return despite a net loss, while Rockfire Resources secured £3.0 million for exploration, and Valterra Platinum achieved an investment grade credit rating. Separately, GSK received two positive CHMP opinions for its respiratory treatments Nucala and depemokimab, as PensionBee gained OTCQX qualification for enhanced US investor access.
Taylor Maritime TMIP, the specialist dry bulk shipping company, released its unaudited interim results for the six months ended 30 September 2025, reporting a total shareholder return of 8.1%. The company achieved net charter revenue of $68.4 million and an adjusted EBITDA of $18.2 million, although it recorded a net loss of $(32.1) million. A key highlight was the elimination of all bank debt, demonstrating decisive execution and consolidation during a period of geopolitical uncertainty and market volatility.
Global mining technology leader Weir Group WEIR announced its binding agreement to acquire the remaining 50% share of its Chile-based joint venture, ESEL, for £56 million. The acquisition is set to strengthen Weir's direct market channels and manufacturing footprint in South America, supporting capacity optimisation across its global foundry network. This move is expected to accelerate long-term growth for Weir in the crucial LATAM mining region.
Life and pensions consolidator Chesnara CSN has secured the necessary UK regulatory approval for its previously announced £260 million acquisition of HSBC Life (UK) Limited. This significant development allows the company to progress towards completing the transaction, which is now expected to finalise by the end of January 2026. The acquisition will further expand Chesnara's policy administration in the UK market.
Global pharmaceutical company GSK GSK announced that its drug Nucala (mepolizumab) received a positive opinion from the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP). The recommendation is for Nucala as an add-on maintenance treatment for uncontrolled chronic obstructive pulmonary disease (COPD) characterised by raised blood eosinophils. This move could provide a new therapeutic option for millions of European patients, with a final European Commission approval decision anticipated in the first quarter of 2026.
Following another positive development for the healthcare giant, GSK GSK's depemokimab has received a favourable opinion from the European Medicines Agency's CHMP for two indications: severe asthma with type 2 inflammation and chronic rhinosinusitis with nasal polyps. This potential approval would introduce the first and only ultra-long-acting biologic in the EU for respiratory diseases. The positive opinion stems from four phase III trials that demonstrated statistically significant and clinically meaningful primary endpoints.
Mineral exploration company Rockfire Resources ROCK announced a proposed placing aimed at raising £3.0 million, before expenses. The company will issue 2,307,692,298 new ordinary shares at a price of 0.13 pence per share. This capital raise is conditional upon allotment and admission, and is vital for funding ongoing and future exploration projects for base metals, precious metals, and critical minerals.
Mining company SolGold SOLG announced a revised non-binding indicative cash offer from Jiangxi Copper (Hong Kong) Investment Company for 28 pence per SolGold share. The offer targets the entire issued and to be issued share capital not already held by Jiangxi Copper. SolGold's board has indicated its readiness to recommend this Revised Possible Offer to shareholders, suggesting a significant step towards a potential acquisition.
Near-term uranium developer Neo Energy Metals NEO provided a detailed update on the ongoing regulatory processes and project integration workstreams for its conditional acquisition of the Beisa Uranium and Gold Project from Sibanye-Stillwater. The project, located in South Africa, encompasses the Beatrix 4 shaft complex with significant resources of 1.2 million ounces of gold and 26.9 million pounds of uranium. The company's executive management has commenced a comprehensive implementation assessment to advance the project.
Specialist dry bulk shipping company Taylor Maritime TMIP announced its plan to return approximately $143.4 million to shareholders in the first quarter of 2026. This significant capital distribution is intended to be made via a partial compulsory redemption of ordinary shares, with further details on pricing and timetable to be published in a shareholder circular in January 2026. This action comes in addition to the company's regular quarterly dividend, underscoring its commitment to shareholder returns.
Online retirement savings provider PensionBee Group PBEE announced its qualification to trade on the OTCQX Best Market in the United States, under the ticker symbol PBNYF. While maintaining its primary listing on the London Stock Exchange, this strategic move aims to enhance international investor access and support improved, cost-effective trading convenience for its shares. The admission to OTCQX is reserved for companies meeting strong financial criteria and adhering to recognised corporate governance practices.
Mining company Valterra Platinum VALT has received an investment-grade credit rating from S&P Global Ratings, with long-term foreign and local currency issuer credit ratings of BBB- and a short-term rating of A-3, both with a stable outlook. This positive assessment highlights the company's strong balance sheet and robust free cash flow generation, which is underpinned by the quality of its assets and disciplined capital allocation. The rating is a key indicator of financial stability and can influence borrowing costs.